Ñî¹óåú´«Ã½

PHILADELPHIA, Dec. 22 – The Ñî¹óåú´«Ã½ (ACP) supports the recommendation of the Advisory Committee on Immunization Practices (ACIP) to the Centers for Disease Control and Prevention (CDC) for the use of the COVID-19 vaccine from Moderna, Inc. to be used in persons 18 and older in the U.S. under the Food and Drug Administration’s Emergency Use Authorization. ACP previously announced its support for the ACIP recommendations to the CDC for the use of the Pfizer-BioNTech COVID-19 vaccine.

Panel offers timely, evidence-based advice for promoting vaccine confidence and uptake

PHILADELPHIA, Dec. 15, 2020 – The Ñî¹óåú´«Ã½ (ACP), representing 163,000 internal medicine physicians, supports the recommendation of the Advisory Committee on Immunization Practices (ACIP) to the Centers for Disease Control and Prevention (CDC) for the use of the Pfizer-BioNTech COVID-19 vaccine in persons 16 and older in the U.S. under the Food and Drug Administration’s Emergency Use Authorization. ACP also supports the addition of an amendment to the 2021 Adult Immunization Schedule to include use of COVID-19 vaccines.

Washington, DC (December 10, 2020) — In a letter sent today to President-elect Joe Biden, the Ñî¹óåú´«Ã½ (ACP) offered detailed recommendations on how his administration can help ensure the greater good of public health in the United States of America once they get into office.

Washington, DC (Dec. 9, 2020) —While the 2021 Medicare Physician Fee Schedule (MPFS) makes historic enhancements to payments to physicians for evaluation and management (E/M) services, the Ñî¹óåú´«Ã½ (ACP) says there are still improvements that the Centers for Medicare & Medicaid Services (CMS) should make to help patients and physicians, especially in light of the COVID-19 pandemic.

National Influenza Vaccination Week reminds us that getting a flu shot is more important than ever

PHILADELPHIA, Dec. 3, 2020 – The Ñî¹óåú´«Ã½ (ACP) is urging all adults to mark National Influenza Vaccination Week (Dec. 6-12) by making sure they get vaccinated as flu season and winter weather are here.

 Urges Congress to Fully Support Implementation on January 1 as Finalized by CMS

Statement attributable to:
Jacqueline W. Fincher, MD, MACP
President, Ñî¹óåú´«Ã½

Washington, DC (November 30, 2020) — In a new policy paper released today, The Ñî¹óåú´«Ã½ (ACP) warned against the potential negative impact that cost-cutting step therapy policies and nonmedical switching of prescription drugs can both have on patient safety.

Philadelphia, PA (Nov. 24, 2020) â€“ In a new policy statement, the Ñî¹óåú´«Ã½ (ACP) recommends a framework for the ethical and phased allocation of vaccines to the U.S. population to slow down and prevent the spread of COVID-19, recognizing that vaccine supplies will be limited and may have varying levels of effectiveness in different populations.